Bibliography
Found 22 results
Filters: Author is Misra, Vikas [Clear All Filters]
Identification of Hepatic and Mitochondrial Pathways Linked to Lipid Abnormalities in HIV Patients on Suppressive ART through Metabolomic Profiling. In: Conference on Retroviruses and Opportunistic Infections. Conference on Retroviruses and Opportunistic Infections. Seattle, WA; 2012.
. Monocyte Activation Markers in Cerebrospinal Fluid Are Associated with Impaired Neurocognitive Testing in Advanced HIV Infection. In: AAN Meeting. AAN Meeting. New Orleans, Louisiana; 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22569268
. Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults. EClinicalMedicine. 2021 ;31:100697.
Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression. J Acquir Immune Defic Syndr. 2015 ;69(1):18-28.
. Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1087-1097. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24259252
. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis. 2017 ;17(1):151.
. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy. AIDS. 2019 ;33(4):615-625.
. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS [Internet]. 2014 ;28(11):1579-1591. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24752083
. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014 ;28(11):1579-91.
. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy. Viruses. 2023 ;15(9).
. Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy. Sci Rep. 2018 ;8(1):7227.
. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018 ;67(8):1182-1190.
. Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy. Viruses. 2023 ;15(4).
. Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy. J Infect Dis. 2020 .
. Multimorbidity networks associated with frailty among middle aged and older people with HIV. AIDS. 2021 .
. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS ONE [Internet]. 2012 ;7(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/22363505
. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infectious Diseases [Internet]. 2013 ;13:203. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23641933
. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J Neuroinflammation. 2019 ;16(1):254.
. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients. BMC Immunol. 2020 ;21(1):57.
. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 ;75(2):246-255.
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023 ;37(14):2137-2147.
. .